3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
9
Non-metastatic Castration-resistant Prostate Cancer
4
Neoplasm Metastasis
2
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
2
Urogenital Neoplasms
1
Sleep Initiation and Maintenance Disorders
1
Non-metastatic Prostate Cancer
1
Metastatic Hormone-sensitive Prostate Cancer
1
Fatigue
1
Depression
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Advanced Prostate Carcinoma
1
Interventions
Surveys and Questionnaires
2
ziprasidone
1
pegfilgrastim
1
enzalutamide
1
darolutamide
1
apalutamide
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Standard of Care
1
Spironolactone
1
Siberian ginseng root
1
Sevelamer
1
Rocuronium
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Palliative Care
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Lurasidone Hydrochloride
1
Labetalol
1
Haloperidol
1
Granulocyte Colony-Stimulating Factor
1
Fosfomycin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Sleep Initiation and Maintenance Disorders
×
darolutamide
×
Clear all
NCT07181122
2026-04-28
PRO-MIND
Ankara Etlik City Hospital
Recruiting
102 enrolled